CoreWeave (CRWV)

Last updated: 2026-10-25 · Author: Claude (claude-fable-5-1 subagent) · Status: reviewed · Reviewer: Codex (gpt-6-astra) cross-check, applied 2026-10-17 · Updated 2026-10-21 from signals/2026-10-21.md · Updated 2026-10-25 from signals/2026-10-25.md

Summary

  • CoreWeave buys Nvidia GPUs and rents compute under committed contracts to customers including Microsoft, OpenAI, Meta, Nvidia and Jane Street. Q2 2026 revenue was $2.575bn (+112% y/y); 2026 revenue guidance is $12.4–13.2bn. June backlog was $104.2bn, excluding >$25bn of commitments announced in early Q3; those announcements are not an October backlog balance. The three largest customers supplied 72% of Q2 revenue (claims 1, 11–19).
  • Expansion depends heavily on external financing. June debt principal was $35.551bn and operating lease liabilities $16.319bn, or $51.870bn combined. Identified subsequent gross borrowing additions of $6.6bn imply $42.151bn debt before repayments and other movements. Capex guidance is $35–39bn; another $35.5bn of undiscounted uncommenced lease payments sits outside recognized lease liabilities. The September ATM is a financing option, not evidence of cash raised (claims 10, 20–25, 41, 47).
  • CoreWeave is not GAAP-profitable at its current scale and financing cost. Q2 adjusted EBITDA was $1.510bn (59% margin), but D&A of $1.393bn and net interest of $640m explain most of the bridge to a $626m net loss. Growth can create costs before revenue contribution; it does not make profitability impossible (claims 3–8).
  • Q2 adjusted EBITDA covered net interest 2.36×; this does not establish cash coverage of principal and interest. H1 CFO less cash PP&E purchases was −$10.454bn before principal repayments. Delivery spending, cash collection timing, prepayments, restricted cash and borrower-level obligations determine liquidity; RPO is a revenue-recognition schedule (claims 13, 24, 48, 52).
  • October credit and equity markets sharply repriced risk. CNBC reports five-year CDS ~1,082bp on 19 October, nearly 1,081bp on 20 October and 1,065.84bp on 21 October; the 9.75% 2031 yield was 15.97% on 20 October. These are secondary snapshots, not synchronized closes. Shares closed at $61.39 on 16 October, down 25.2% for the week. IFR’s 23 October report describes sector financing delays, while the CEO says CoreWeave retains borrowing, equity and prepayment options. This establishes financing pressure, not that every funding channel has closed or a default has occurred (claims 31, 33–34, 41, 55–58).
  • Equity is residual and exposed to dilution; unsecured creditors lack secured lenders' collateral priority, but recoveries depend on each borrower, collateral and guarantees. June DDTLs totalled $13.643bn; identified unsecured notes/converts total $20.817bn after September. Nvidia's January holdings would equal about 8.6% of June total shares if unchanged, and its $6.3bn capacity arrangement has delivery conditions and termination rights (claims 17–18, 21–22, 48–49).
  • GPU renewal pricing remains a risk, particularly for DDTL 5.5's five-year debt against contracts averaging three years. Six-year depreciation does not prove that every GPU needs renewals to recover its cost. Management reports A100/H200 renewals and attractive initial-term returns; those disclosures challenge the original thesis but do not establish audited fleet-wide returns. OCPI settled H100 at $3.02, H200 at $6.20 and B200 at $9.57/GPU-hour on 24 October; dated Silicon Data H100 was $2.88 on its separate basis. These support current paying demand without establishing fleet-wide renewal returns. The timing of the first large renewal cohort remains unverified (claims 28, 30, 39, 43–45, 53, 57).

Key claims

# Claim Value As of Source Type Grade
1 Quarterly revenue $2,575m (+112% y/y, +24% q/q) 2026-Q2 Q2 2026 release primary / derived A dollars; B recalculated growth
2 Revenue by quarter, 2025-Q1 to 2026-Q2 $982m, $1,212m, $1,365m, $1,572m, $2,078m, $2,575m; Q2 2025 uses the current comparative, replacing the original release’s $1,213m 2026-Q2 releases 12, 10, 8, 6, 4, 2; Q2 2026 10-Q, income statement; see data/coreweave-quarterly.csv primary A
3 Net loss by quarter, 2025-Q1 to 2026-Q2 −$315m, −$290m, −$110m, −$452m, −$740m, −$626m 2026-Q2 same primary A
4 Interest expense, net, by quarter $264m, $267m, $311m, $388m, $536m, $640m 2026-Q2 same primary A
5 Interest expense / revenue 24.9% (Q2); Q3 guidance $860–940m on $3.45–3.60bn, midpoint 25.5% (endpoint range 23.9–27.2%) 2026-08-11 Q2 release; August outlook, p. 3 primary / derived A guidance; B ratios
6 Adjusted EBITDA by quarter $606m, $753m, $838m, $898m, $1,157m, $1,510m (59% margin in Q2 2026) 2026-Q2 releases primary A
7 Bridge from adjusted EBITDA to net loss, Q2 2026 $1,510m − D&A $1,393m − net interest $640m − SBC $165m − tax $62m − acquisition costs $1m + other income $125m = −$626m 2026-Q2 Q2 release, reconciliation primary / derived A components; B bridge
8 Stock-based compensation by quarter $184m, $145m, $144m, $157m, $153m, $165m 2026-Q2 releases primary A
9 Cash capex (purchase of PP&E) by quarter $1,407m, $2,453m, $2,389m, $4,060m, $7,695m, $6,422m; company-defined capex incl. financed additions $9.4bn in Q2 2026 2026-Q2 10-Qs/10-K cash-flow statements; corrected call, p. 9 primary / derived A disclosed; B quarters derived from YTD
10 Capex guidance 2026 $35–39bn (previously $31–35bn); Q3 $11.5–13.5bn; company-defined capex, not cash PP&E purchases 2026-08-11 August outlook, p. 3; May outlook, p. 3 primary A (management guidance)
11 Revenue guidance 2026 $12.4–13.2bn; adjusted operating income $0.96–1.15bn; exit annualized run-rate revenue $18.5–19.5bn = final month’s revenue ×12, not annual recurring revenue 2026-08-11 August outlook, p. 3 and footnote primary A (management guidance)
12 Revenue backlog $104.2bn at 30 Jun 2026, excl. >$25bn net new commitments announced in early Q3; $66.8bn at Dec 2025; $25.9bn at Mar 2025 2026-Q2 September presentation, slides 28/37; releases 6, 12 primary A
13 RPO and recognition schedule $103.7bn; 41% within 24 months (to Jun 2028), 39% months 25–48, remaining 20% months 49–78; revenue recognition, not cash collections 2026-06-30 Q2 2026 10-Q, Note 2 primary / derived A disclosed; B remainder
14 Largest customer share of revenue Microsoft 67% of FY2025; "Customer A" 72%→71%→67%→45%→36% (Q1 2025→Q2 2026); Customer B 26%, C 10% in Q2 2026 2026-Q2 10-K, 10-Qs primary A (B that A = Microsoft in 2026, labels may change)
15 OpenAI contracts $11.9bn through Oct 2030 (Mar 2025) + up to $4bn (May 2025) + $6.5bn through May 2031 (Sep 2025) ≈ $22.4bn 2025-09-25 10-K; 8-K; IR release primary A
16 Meta contracts Up to $14.2bn through 14 Dec 2031 (Sep 2025); approximately $21bn announced Apr 2026 includes new capacity through Dec 2032 and exercise of a prior additional-capacity option; Reuters reports it as additional to September’s agreement 2026-04-09 September 8-K; April 8-K; Reuters primary / secondary A terms; B additional-value reporting
17 Nvidia capacity arrangement $6.3bn initial order value; purchases residual unsold capacity through 13 Apr 2032, conditional on delivery/availability and subject to termination rights (claim 49) 2025-09-09 Nvidia order 8-K, Item 1.01 primary A; unconditional backstop interpretation unsupported
18 Nvidia equity $2.0bn for 22,935,780 shares at $87.20; 47,213,353 shares held at 23 Jan 2026, 11.5% of Class A then; unchanged holdings / June ~551m total shares ≈8.57%; October holdings not verified 2026-01-23 (holdings); 2026-06-30 (denominator) Placement 8-K; Nvidia 13G/A; Q2 10-Q primary / derived A historical shares/class percentage; B conditional total-equity ratio
19 Jane Street ~$6bn compute commitment + $1bn equity at $109 2026-04-15 8-K ex99.1 primary A
20 Total debt principal $35,551m at Jun 2026 ($21,615m at Dec 2025; $8,807.921m at Mar 2025); June carrying value after discounts/issuance costs $35,068m ($31,405m recourse + $3,663m non-recourse) 2026-06-30 Q2 10-Q, Note 10; 10-K; Q1 2025 10-Q primary / derived A principal/components; B carrying-value sum
21 Debt structure at 30 Jun 2026 DDTL 1.0 $1.300bn (15%, Mar 2028); 2.0 $3.190bn (11%, Aug 2030); 2.1 $3.000bn (9%, Mar 2031); 3.0 $2.215bn (9%, Aug 2030); 5.0 $1.101bn (9%, Nov 2031); 4.0 $2.837bn (7%, Mar 2032, non-recourse with carve-outs): DDTLs $13.643bn total. Straight notes $10.029bn (9.25% 2030, 9.0%/9.75% 2031, 9.625%/€2bn 8.5% 2032); converts $6.588bn (1.75% 2031/2032); OEM/software $5.102bn (9–11%); Magnetar $0.189bn (12%) 2026-06-30 Q2 10-Q, Note 10; DDTL percentages are effective rates, note percentages coupons primary / derived A components; B subtotals
22 Identified gross borrowing additions after quarter-end $4.2bn 2.875% converts due Apr 2033 (conversion $97.85); DDTL 5.5 $2.6bn facility at SOFR+5.5% (Sep 2031), $1.2bn drawn; $1.2bn revolver draw. $6.6bn additions imply $42.151bn before repayments, other draws and FX; not a reported October balance 2026-09-22 Closing 8-K; Q2 10-Q, Note 16 primary / derived A disclosed; B gross-additions illustration
23 Scheduled principal rest of 2026 $4.4bn; 2027 $6.2bn; 2028 $4.4bn; 2029 $2.4bn; 2030 $3.2bn; thereafter $14.9bn 2026-06-30 Q2 2026 10-Q primary A
24 H1 cash flows and debt service Principal $5.219bn + cash interest $0.982bn = $6.201bn; CFO $3.663bn after $0.806bn operating cash interest; $0.176bn interest capitalized; cash PP&E $14.117bn; debt proceeds $16.747bn before repayments, net debt inflow $11.528bn; equity $2.982bn; net financing cash flow $13.985bn 2026-H1 Q2 10-Q, cash-flow statement and debt-service disclosure primary / derived A disclosed; B sums/netting
25 Operating lease liabilities $16.319bn ($0.584bn current + $15.735bn non-current); debt principal + operating lease liabilities $51.870bn, excluding separate finance leases and uncommenced commitments 2026-06-30 Q2 10-Q, balance sheet and Note 8 primary / derived A liabilities; B sum
26 Collateral in SPVs $18.2bn non-current and $2.6bn current assets pledged to SPV facilities (ex DDTL 4.0); DDTL 4.0 SPV holds $3.3bn 2026-06-30 Q2 2026 10-Q primary A
27 DDTL 3.0 covenant relief Minimum liquidity $100m for payment dates on/after 1 Mar and before 1 May 2026; initial DSCR test 31 Oct 2027; contract-realisation test 28 Feb 2026; unlimited equity cures before 28 Oct 2026, then no more than three consecutive calendar months in any four consecutive calendar months (claim 51). This is an existing contractual transition, not a new default or maturity 2025-12-31 amendment; filed 2026-01-02; rechecked 2026-10-25 Amendment 8-K primary A
28 DDTL 4.0 / 5.0 / 5.5 terms 4.0 initially ~$7.5bn, up to $8.5bn at stabilization, A3/A(low), SOFR+2.25% or ~5.9% fixed, non-recourse with carve-outs, unnamed leading AI enterprise customer; 5.0 $3.1bn, Ba2/BB+, SOFR+4.5%, two non-IG customers; 5.5 $2.6bn, Ba2/BB+, SOFR+5.5%, ~5-year loan on contracts averaging ~3 years 2026-08-10 releases 20, 25, 26; Q2 10-Q primary A disclosed terms/ratings; 4.0 customer’s own IG status not independently established
29 Company leverage framing total debt 7.0x FY2025 adj. EBITDA ($3.09bn); 3.3x "LTM run-rate" EBITDA of $16.1bn on fully drawn $53.5bn; EV $69.5bn at 7 Apr 2026 2026-04-07 notes offering supplement primary / derived A company framing; B ratios on stated inputs; numeric slide not independently reverified by review
30 Depreciation life technology equipment 6 years (changed from 5 in 2023); gross technology equipment $33.8bn, CIP $11.9bn 2026-06-30 10-K; Q2 2026 10-Q primary A
31 Share price IPO $40 (28 Mar 2025); peak $183.58 (20 Jun 2025); $82.08 (9 Oct 2026); $65.78 (14 Oct, −15.5%); $69.69 (15 Oct, +5.9%); $61.39 (16 Oct, −11.9%); week −25.2% 2026-10-16 Yahoo Finance chart API secondary (market data) B
32 September CPI (released 14 Oct) headline 3.7% y/y vs 3.6% exp.; core 2.6% vs 2.5%; core m/m 0.33% vs 0.2%; Oct hike odds 21%→47% 2026-10-14 investinglive secondary C
33 5-year CDS >1,000bp stress corroborated; Bloomberg reports ICE intraday record 1,194.5bp on 15 Oct and >60% model-implied five-year default probability; June ~452bp point remains unverified. CNBC: ~1,082bp on 19 Oct; nearly 1,081bp on 20 Oct (+13% week). FT reports ~1,090bp in its 20 Oct article without a fixing time; not a verified 19 Oct close. CNBC/FactSet subsequently reports 1,065.84bp on 21 Oct, fixing time unspecified. A separate CNBC article published 21 Oct and updated 23 Oct says last 1,145bp without a fixing date; retain as an undated publication snapshot, not a 22/23 Oct close 2026-10-15, 19–21; undated quote in 21 Oct article updated 23 Oct Bloomberg (review fetched lead; direct fetch unavailable); Axios; TNW; CNBC 19 Oct; CNBC 20 Oct; FT/Financial Post; CNBC/FactSet 22 Oct; CNBC updated 23 Oct secondary B broad stress; C individual quotes/model estimate; no primary time series
34 Bond yields and conflicting snapshots >15% stress corroborated; CNBC snippets: 14.8%/14.9% on 14 Oct; MT Newswires quotes 15.78% for 9.75% 2031s on 15 Oct. 9.625% 2032s: TradingNews ~78/>16% on 15 Oct; BondTerminal 81.504/14.45% YTW dated 15 Oct; times/methods differ. New CNBC snapshots: 9.625% 2032 YTM 14.9% on 19 Oct; 9.75% 2031 YTM 15.97% on 20 Oct. CNBC’s article published 21 Oct/updated 23 Oct also quotes unsecured yield ~15% without a security or fixing date: publication snapshot only, not a new dated yield. Distinct bonds and dates, not one continuous yield series 2026-10-14–16, 19–20; undated quote in 21 Oct article updated 23 Oct CNBC 14 Oct (snippet); Axios; MT Newswires; TradingNews; BondTerminal; CNBC 19 Oct; CNBC 20 Oct; CNBC updated 23 Oct secondary / tertiary B broad stress; C exact secondary quotes; D tertiary/aggregator marks; no TRACE verification
35 Corporate ratings Moody’s Ba3, S&P B+, Fitch BB−; not independently rating-agency-verified 2026-10 TradingNews tertiary D
36 Core Scientific all-stock merger agreed 7 Jul 2025; CORZ holders voted it down 30 Oct 2025; agreement terminated 2025-10-30 8-K primary A
37 Insider selling 100 Form 144 notices filed 13 Jul–13 Oct 2026 (24 Jul, 50 Aug, 22 Sep, 4 Oct); CEO Form 4 of 25 Aug 2026 shows 10b5-1 sales at $88–90, direct stake ~1.49m shares after 2026-10-13 EDGAR Form 144 list; Form 4 primary A/B
38 Lock-up Coatue put right (1.2bn at $38.95) terminated 25 Sep 2025 once stock traded above $68.16 VWAP outside lock-up, implying lock-ups had lapsed 2025-09-25 8-K primary A
39 GPU rental prices OCPI settlements 20 Oct: H100 SXM $3.12/GPU-hour (+4.7% day/−1.6% week/+17.7% month), H200 $6.16, B200 $8.83 (+5.0%/+12.8%/+14.5%). Subsequent H100 21/22/23/24 Oct: $3.09/$3.15/$3.17/$3.02; B200: $9.40/$9.32/$9.58/$9.57. On 24 Oct H200 $6.20; H100 +8.6% 7d/+3.4% 30d, B200 +12.9%/+19.5%. Retrospectively retrieved daily publisher settlements, including Saturday 24 Oct; no 25 Oct settled print. Index settlements are not CoreWeave contract rents or utilization. Prior Uvik H100 on-demand median $4.20 across 16 providers (7 Oct), SemiAnalysis 1-year $1.70→$2.35 (Oct 2025→Mar 2026, +38.2%) remain unverified tertiary observations; management’s ~25% July rise remains a separate disclosure 2026-10-20–24 (OCPI); 2026-10-07 (Uvik); 2026-09-17 (management) Ornn H100; Ornn B200; Ornn panel; Ornn H200; Uvik; September presentation, slide 7 primary / tertiary A publisher readings and management statement; D older Uvik/index figures; representativeness not established
40 Litigation Securities action filed 12 Jan 2026; four derivative actions by May (three New Jersey, one Delaware); no material potential loss accrued 2026-06-30 Q2 10-Q, Note 9 primary A
41 ATM equity-financing mechanism Up to 35m Class A shares, including collared forwards; ~$2.15bn gross at $61.39 and 6.35% of June ~551m existing shares if fully sold at that price; authorization is not issuance. 8-K anticipated no sales until at least 30 days after convert purchase agreement 2026-09-17 ATM release; September 8-K; Q2 10-Q for share denominator; claim 31 for price primary / derived scenario A program/restriction disclosure; B conditional arithmetic
42 September convert net liquidity $4,137.0m proceeds after purchaser discounts, before offering expenses; capped calls cost $566.2m; $3,570.8m remains before remaining expenses 2026-09-22 Closing 8-K, Item 1.01 primary / derived A disclosed; B residual
43 Disclosed renewal examples A100 renewal extends into 2029; H200 renewal for three years at a premium to original pricing; examples do not establish fleet-wide returns 2026-09-17 September presentation, slide 10 primary A (management disclosure)
44 New-deal prepayments and expected margins ~70% of Q2-signed deals included prepayment; expected contribution margins 5–10 percentage points above recent-quarter deals 2026-09-17 September presentation, slide 7 primary A (management disclosure/expectation)
45 Selected contract pricing and latest disclosed contracted power Q3 three-to-six-month contracts at ~$40m/MW annualized revenue; contracted power ~4.2GW at 11 Aug, versus ~3.7GW at June; selected pricing is not a fleet average 2026-09-17 (pricing); 2026-08-11 (power) Pricing update primary A (company disclosure)
46 India expansion Planned 240MW with AdaniConneX; first phase expected mid-2028; opportunity for up to another 240MW. No capex amount or signed end-customer backlog value disclosed in release 2026-10-07 India announcement primary A (announced plan)
47 Undiscounted lease commitments Existing operating leases $29.135bn undiscounted versus $16.319bn recognized present value; uncommenced leases $35.5bn undiscounted, excluding specified uncertain arrangements including a site with $14.7bn contractual maximum 2026-06-30 Q2 10-Q, Note 8 primary A
48 Liquidity and DDTL recourse Cash/equivalents $5.524bn, securities $0.015bn; separate restricted cash $0.873bn current/$0.507bn non-current; facility availability $10.014bn at June. Management expected resources/borrowing availability to cover next year’s obligations. June DDTLs other than 4.0 have parent guarantees; 4.0 has limited carve-outs 2026-06-30 (balances); 2026-08-12 (filing assertion) Q2 10-Q, balance sheet, Note 10 and liquidity discussion primary A balances/terms/management assertion; not an independent liquidity stress test
49 Nvidia protection conditions Capacity purchases require delivery/availability; MSA allows termination for breach and specified bankruptcy/insolvency circumstances; not a debt guarantee 2025-09-09 Nvidia order 8-K, Item 1.01 primary A disclosed conditions; insolvency enforceability not assessed
50 Meta commitment clarification March order adds new capacity and exercises a prior additional-capacity option; Reuters describes ~$21bn as additional to September’s $14.2bn. Announced commitments are not remaining backlog 2026-04-09 April 8-K, Item 8.01; Reuters primary / secondary A contract description; B additional-value reporting
51 Equity cures after relief window Unlimited cures before 28 Oct 2026; thereafter no more than three consecutive calendar months in any four consecutive calendar months; first DSCR test 31 Oct 2027. 28 Oct is neither an automatic default nor a debt maturity and does not end all cures 2025-12-31 amendment; filed 2026-01-02; rechecked 2026-10-25 Amendment 8-K primary A terms
52 Deferred revenue balance versus cash-flow contribution $9.692bn at June versus $8.185bn at December: +$1.507bn balance growth; $1.365bn is the separate H1 cash-flow reconciliation contribution 2026-06-30 Q2 10-Q, balance sheet/cash-flow statement primary / derived A balances/contribution; B growth
53 Management’s initial-term-return position Management says initial contracts repay asset-level debt and deliver attractive returns before renewals; current renewal exposure described as limited portion of fleet. Not independently verified cohort returns 2026-08-11 Corrected transcript, pp. 8, 11 primary A that management made the assertions
54 Ineffective disclosure controls and material weaknesses; remediation “Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of June 30, 2026 due to the material weaknesses in our internal control over financial reporting described below.” Material weaknesses: “lack of effectively designed, implemented, and maintained IT general controls over applications that support our financial reporting processes; insufficient segregation of duties across financially relevant functions, and lack of sufficient number of qualified personnel within our accounting, finance, and operations functions who possessed an appropriate level of expertise to provide reasonable assurance that transactions were being appropriately recorded and disclosed.” These weaknesses continued at June 30; the filing says the deficiencies did not cause a material financial-statement misstatement. Remediation actions taken/planned: engage external Sarbanes-Oxley consultants; implement IT access/program-change controls and evaluation/monitoring of key application controls/reports; implement processes/controls to identify and manage segregation-of-duties risks; design/implement significant-account and disclosure controls, including reconciliations and journal-entry preparation/review; continue hiring accounting, finance and operations staff with sufficient technical expertise and separation of conflicting duties; consult experts on technical accounting, internal controls and financial-statement preparation. Management review and audit committee oversight continue; completion and testing over a sufficient period are required before management can conclude remediation is effective, and further measures may be needed 2026-06-30 (assessment); 2026-08-12 (filing) Q2 10-Q, Part I, Item 4, pp. 49–51 (accessed 2026-10-18) primary A
55 Financing-access assessment Goldman’s 19 Oct Buy upgrade favors project financing; this is an analyst view, not an arranged loan 2026-10-19; reported 2026-10-20 Axios secondary analyst attribution B attribution
56 Supplier view of neocloud demand and capital Huang told CNBC in Berlin that neocloud demand is exceptionally strong but scarce working capital constrains growth; he expects the constraint to be solved and flags European power allocation. Supplier opinion, not a new quantified customer order, bank commitment or assured rescue 2026-10-22 CNBC interview secondary attributed management opinion B attribution; C prognosis
57 Separate Silicon Data H100 benchmark Dated neocloud SDH100RT card/chart: 21/22/23/24 Oct $2.86/$2.88/$2.90/$2.88 per GPU-hour. Same page’s undated FAQ still says $2.53. Prefer dated card/chart, retain internal conflict; Saturday point is publisher-dated, not proof of independent same-day capture or complete-month publication coverage 2026-10-21–24; retrieved 2026-10-25 Silicon Data H100 page and embedded chart primary benchmark publication A dated publisher display; C freshness/coverage suitability
58 New financing-access reporting and company response IFR reports five datacenter IPOs pulled/delayed and other financings on hold; banks underwrote almost $330bn US public AI bonds/loans YTD, almost $100bn datacenter/neocloud. These are sector totals, not CoreWeave new loans. Bernstein’s $85bn funding estimate uses $104bn backlog, not a newly filed funding need or October backlog. CNBC reports the CEO describing infrastructure-backed borrowing, corporate debt, equity and customer prepayments as financing options. Attributed reporting/management views establish pressure and disagreement, not a completed financing, blanket market closure or declared default CNBC published 2026-10-21/updated 23 Oct; IFR published 2026-10-23 (issue 24–30 Oct) IFR; CNBC updated 23 Oct secondary reporting / analyst and management attribution B reporting/attribution; C funding estimate; no realized financing or default inference

Analysis

What the business is and where it sits in the stack

CoreWeave converts Nvidia GPUs into contracted rental revenue. All GPUs in its fleet are Nvidia's (the 10-Q describes this as a contractual obligation to customers), and three unnamed suppliers accounted for 60% of 2025 purchases. Gross technology equipment was $33.823bn at June 2026, plus $11.918bn construction in progress. CoreWeave leases buildings, recognizes $16.319bn of operating lease liabilities and increasingly co-invests in data-center joint ventures (up to $1.7bn committed in H1). Active power grew from 420MW in March 2025 to 1.5GW in June 2026; June contracted power of 3.7GW was superseded by a disclosed 4.2GW at 11 August. The company targets more than 1.85GW active at year-end and more than 5GW of AI factories by 2030 under its January Nvidia framework. Q2 10-Q; releases 12, 19; pricing update.

Long-lived commitments extend beyond recognized liabilities: existing operating leases represent $29.135bn undiscounted payments; another $35.5bn relates to leases not yet commenced, excluding specified uncertain arrangements including a site with a $14.7bn contractual maximum. These are separate undiscounted commitments, not amounts to add to discounted liabilities and call current debt. The planned 240MW India deployment announced on 7 October, first phase expected mid-2028 with an opportunity for another 240MW, adds execution and funding exposure without a disclosed capex or end-customer backlog amount (claims 46–47). Q2 10-Q, Note 8; India announcement.

Ninety-eight per cent of revenue comes from committed contracts, whose initial terms generally range from one to six years. Microsoft supplied 67% of 2025 revenue; Q2 2026's largest customers supplied 36%, 26% and 10%. The A–D labels need not identify the same company across periods, so a continuing Microsoft share trend is an inference. Cumulative announced OpenAI commitments total up to $22.4bn. Meta's September $14.2bn agreement was followed by a March 2026 order, announced in April, covering new capacity and exercise of an existing additional-capacity option; Reuters reports the ~$21bn as additional to September's agreement. Jane Street committed ~$6bn, Nvidia's initial order was $6.3bn and the original Microsoft MSA's value is undisclosed. These announced totals are not remaining RPO. The 10-K explicitly flags OpenAI's credit risk. 10-K; claims 14–19, 50; April Meta 8-K; Reuters.

Profitability: EBITDA is real, profit is not

Adjusted EBITDA margins ranged from 56–62% over the six quarters, with $1.510bn in Q2 2026. The full Q2 bridge in millions is 1,510 − 1,393 D&A − 640 net interest − 165 SBC − 62 tax − 1 acquisition costs + 125 other income = −626. D&A and net interest explain 95.2% of the $2,136m gap. Annualized D&A is $5.572bn, but comparing total D&A with quarter-end gross technology equipment does not validate the six-year useful-life estimate: D&A includes other assets and the fleet changes during the quarter. Q2 release, reconciliation; Q2 10-Q, Note 5 (A components, B arithmetic).

Adjusted operating income was $128m, a 4.97% margin versus $200m/$1,212m = 16.50% a year earlier (company-displayed prior margin 16%). It excludes SBC, acquired-intangible amortization and acquisition costs, so it retains most, not all, D&A. The accumulated deficit was $4.009bn. Q2 net interest absorbed 24.85% of revenue. Q3 guidance midpoints imply 25.53% and interest 3.91× adjusted operating income; endpoint ranges are 23.89–27.25% and 3.31–4.70× respectively. Growth creates deployment costs before full revenue contribution, but growth alone does not rule out future GAAP profitability. Q2 release; August outlook (A reported/guided values, B ratios).

H1 CFO was $3.663bn and benefited from prepayments and other working-capital movements. Deferred revenue increased from $8.185bn to $9.692bn, a $1.507bn balance-sheet rise; the cash-flow reconciliation contribution was separately $1.365bn. Management reports prepayments in about 70% of Q2-signed deals and expected contribution margins 5–10 percentage points above recent deals. These terms can reduce upfront funding needs, but deferred revenue also represents future delivery obligations; neither measure establishes future unencumbered cash (claims 44, 52). Q2 10-Q; September presentation, slide 7.

Financing: the loan stack

June debt principal was $35.551bn; the carrying amount after discounts and issuance costs was $35.068bn. Adding the September $4.2bn convert, $1.2bn DDTL 5.5 draw and $1.2bn revolver draw gives $42.151bn. This is an identified gross-additions illustration before repayments, other draws and FX movements, not a reported September or October balance. Q2 10-Q; closing 8-K.

  1. GPU-backed delayed-draw term loans. June balances total $13.643bn, or $14.843bn including the disclosed August draw before other subsequent movements. SPVs pledge particular equipment and contracts; most June DDTLs also have parent guarantees. Blackstone, Magnetar and Coatue participated in the early facilities; Morgan Stanley, MUFG and JPMorgan lead later bank syndicates. DDTL 4.0 is non-recourse except for customary carve-outs, rated A3/A(low), with ~$7.5bn initially available and up to $8.5bn at stabilization, priced at SOFR+2.25% or ~5.9% fixed. The facility rating does not establish the unnamed customer's own rating or guarantee recovery. DDTL 5.0 is $3.1bn, Ba2/BB+, SOFR+4.5%, serving two non-IG customers. DDTL 5.5 is $2.6bn, Ba2/BB+, SOFR+5.5%, with approximately five-year debt against contracts averaging three years: lenders explicitly underwrite renewal risk. Pledged collateral excluding 4.0 was $18.2bn non-current and $2.6bn current. The old ~$25bn committed-DDTL total is not reconciled and cannot be treated as undrawn liquidity. Q2 10-Q, Note 10; releases 20, 25, 26.
  2. Unsecured notes and converts. June straight notes of $10.029bn plus converts of $6.588bn and September's $4.2bn convert total $20.817bn, before subsequent movements. The September conversion price of $97.85 was 22.5% above issuance-day reference $79.88 and is 59.4% above $61.39; the stock is 37.3% below conversion. April capped calls cost $492m; September capped calls cost $566.2m. September proceeds after purchaser discounts were $4,137.0m; subtracting capped calls leaves $3,570.8m before remaining offering expenses, materially below principal (claim 42). Q2 10-Q; closing 8-K (A inputs, B arithmetic).
  3. Vendor and bank lines. OEM/software financing was $5.102bn at 9–11% effective rates, with a separate $0.189bn Magnetar loan. The revolver is $2.5bn committed, with availability reduced by borrowings and letters of credit; $1.2bn was drawn in August and June letters of credit were $533m. These balances reconcile the $42.151bn gross-additions illustration. Q2 10-Q; 10-K.

The April noteholder presentation frames December debt/$3.09bn FY2025 adjusted EBITDA as 7.00× and a fully drawn $53.5bn stack/$16.1bn “LTM run-rate” EBITDA as 3.32×. The latter EBITDA is 2.67× annualized Q2 actual EBITDA of $6.04bn. Using the actual denominator gives 5.89× June debt, 6.98× gross-additions debt, or 8.86× the April fully drawn illustration. These are different dates and scenarios, not interchangeable leverage measures; the review checked the April-input arithmetic but could not independently read the numeric slide. April supplement; Q2 release; Q2 10-Q (B calculations on stated inputs).

DDTL 3.0's amendment aligned financing with delivery timing: $100m minimum liquidity applied to March/April payment dates, DSCR testing starts 31 October 2027, and contract-realisation testing was deferred to 28 February 2026. Unlimited equity cures apply before 28 October 2026; thereafter cures are permitted no more than three consecutive calendar months in any four consecutive calendar months (claim 51). The date alone is neither a default nor the end of all cures. Amendment 8-K.

The September 35m-share ATM, including collared forwards, provides an actual equity-financing mechanism. At $61.39 it would represent ~$2.15bn gross and shares equal to 6.35% of June's existing share count if fully sold at that price. It authorizes issuance rather than proving proceeds; the announcement anticipated at least a 30-day sales restriction after the convert purchase agreement. June disclosures separately identify $5.524bn cash/equivalents, $0.015bn securities and $10.014bn facility availability, plus $1.380bn restricted cash. That availability is dated and conditional, and restricted cash is not freely available parent liquidity. Management expected resources and borrowing availability to cover the year following the filing; that assertion needs a cash-flow stress test (claims 41, 48). ATM release; September 8-K; Q2 10-Q.

Can contracted revenue service the debt? The arithmetic

RPO of $103.7bn × 41% gives $42.517bn of revenue recognition over two years, averaging $21.2585bn annually versus a $10.300bn Q2 revenue run-rate, or 2.064×. There is no evidence of even annual recognition or matching cash collections. At an assumed 55–60% EBITDA margin, this scenario produces $11.692–12.755bn annual EBITDA; it is an estimate, not “contracted EBITDA.” RPO includes already-billed amounts, so some future recognized revenue will not generate new cash in that period. Q2 10-Q, Note 2; Q2 release (B revenue arithmetic; C assumed-margin scenario).

For illustration, 8% on $42.151bn is $3.372bn annual interest; annualized Q3 net-interest guidance is $3.44–3.76bn. The earlier blended-rate calculation, $592m ×4 / an estimated $30bn average debt, is 7.89%, not 7.8%, but that average debt is undocumented and cannot validate a rate. Contractual interest, net P&L interest and cash interest differ. Adding $6.184bn of June-scheduled 2027 principal to $3.372bn assumed interest gives $9.556bn service and 1.22–1.33× hypothetical EBITDA coverage. H2 2026 principal of $4.413bn is a half-year amount: annualizing it plus the same interest gives $12.198bn and only 0.96–1.05× illustrative coverage. These scenarios mix a two-year revenue average with incomplete post-June debt schedules. Neither proves liquidity or borrower-level debt-service coverage. Q2 EBITDA/net interest is 2.36×, not a contracted-cash-flow result or an SPV DSCR. Q2 10-Q, Note 10; August outlook (C financing/coverage scenarios).

Company capex/revenue guidance is 2.89× at midpoints, with an endpoint range of 2.65–3.15×, but that is not an external funding requirement. H1 CFO of $3.663bn less cash PP&E of $14.117bn leaves −$10.454bn before $5.219bn principal repayments, or −$15.673bn after principal. CFO already includes $806m operating cash interest; $176m capitalized interest is part of investment. Do not subtract $6.201bn total debt service again. Debt issuance proceeds of $16.747bn were before repayments, leaving $11.528bn net debt cash inflow; equity proceeds were $2.982bn. Net financing cash flow after capped calls and other uses was $13.985bn. Known Q3 gross borrowing additions are $6.6bn, not a complete quarterly cash bridge. Q2 10-Q; closing 8-K (A disclosed, B sums/netting).

The funding dependence is clear, but a further $30–40bn funding need does not follow directly from $35–39bn capex guidance. It requires cash generation, prepayments, committed draws, repayments and other uses to be modeled. High secondary yields raise the prospective cost of new unsecured funding without resetting existing fixed coupons or proving issuance impossible. September's successful convert and ATM authorization predate the October selloff; neither proves post-selloff access, nor does the evidence establish that every channel closed. The cross-check found no verified post-selloff failed financing, missed payment or new corporate downgrade in its bounded search. A 21 October re-fetch of the SEC submissions inventory found the latest issuer filing dated 14 October (Form 4), with the latest 8-K dated 22 September; no 17–21 October 8-K or financing disclosure was located there. This is a bounded filing search, not proof about private negotiations or a new funding event. SEC inventory. IFR’s 23 October report adds evidence of sector issuance delays and reluctant lenders (claim 58), while CNBC reports the CEO describing several financing options and Huang frames the constraint as scarce working capital rather than absent demand (claim 56). These are reporting and attributed views, not proof of a closed CoreWeave financing or a declared default. Bernstein’s quoted $85bn estimate uses a $104bn backlog perimeter; it does not supersede the dated backlog and separate early-Q3 commitments in claim 12. IFR; CNBC; Huang interview.

Per MW, net in-service PP&E is $46.736bn − $11.918bn = $34.818bn, or $23.212m/MW on 1,500MW quarter-end power. Annualized Q2 revenue and actual EBITDA are $6.867m and $4.027m/MW-year. Net in-service PP&E/annualized EBITDA is 5.76 years, about 5.8; using gross in-service PP&E of $40.704bn gives 6.74 years. Neither ratio measures original-investment payback: mixed cohorts, prior depreciation, non-GPU assets and ramping-quarter earnings prevent that inference. A stylized fully debt-funded 9% charge on $34.818bn costs $3.134bn/year and leaves $2.906bn from $6.04bn EBITDA, a roughly 12-year ratio; actual debt amortizes and is not all priced at 9%. It does not prove that initial contracts fail to recover capital. Q2 10-Q, balance sheet/Note 5; Q2 release (B accounting ratios; C financing scenario).

Selected Q3 short contracts priced at ~$40m/MW annualized revenue, stronger expected contribution margins and disclosed renewals materially qualify that static fleet calculation. They cannot be extrapolated to the entire fleet. Cohort costs, stabilized margins, debt amortization and residual values are needed to establish returns (claims 43–45, 53). Pricing update; September presentation; corrected call.

Management's unaudited operating claims about initial-term returns, renewals and ~$40m/MW contracts should be read in light of the CEO/CFO conclusion that disclosure controls were ineffective because of continuing material weaknesses (claim 54). Q2 10-Q, Item 4.

Renewal risk, 2027–2029

The original 2027–2029 window is a risk horizon, not a verified first large renewal cohort: DDTL maturities and RPO recognition dates do not identify contract expiries. Six-year depreciation versus a hypothetical three-to-five-year contract leaves one-to-three accounting years, but initial contracts generally range from one to six years, and an accounting tail need not represent unrecovered investment. DDTL 5.5's five-year debt against contracts averaging three years is direct evidence of renewal exposure. 10-K; DDTL 5.5 release.

Claim 39 preserves primary OCPI settlements of H100 $3.12, H200 $6.16 and B200 $8.83/GPU-hour on 20 October and appends 21–24 October observations. The latest 24 October settlements are H100 $3.02, H200 $6.20 and B200 $9.57; H100 is up 8.6% over seven days and 3.4% over thirty, B200 up 12.9% and 19.5%. Claim 57 adds the separate Silicon Data H100 dated card/chart, $2.88 on 24 October, while retaining its conflicting undated $2.53 FAQ. These retrospectively retrieved index readings do not establish CoreWeave realized contract prices, utilization, collateral recoveries or complete-month benchmark coverage. The older tertiary $1.70→$2.35 H100 contract-index comparison remains unverified and is not spliced into OCPI. Ornn H100; Ornn B200; Ornn panel. Management's ~25% July price increase, A100 renewal into 2029 and three-year H200 renewal above original pricing are primary company disclosures. Management also says initial contracts repay asset debt and generate attractive returns, with near-term renewal exposure limited. Those are material counterevidence to universal renewal dependence, not independently audited cohort returns. September presentation, slides 7/10; corrected call, pp. 8/11.

A 50% rental-price decline can be used as an explicit stress assumption, not an observed outcome or a deduction from each GPU generation's performance. Its effect depends on cohort costs, outstanding debt and replacement demand. Nvidia's $6.3bn capacity arrangement may support utilization but requires delivery/availability and permits termination for breach and specified insolvency events. It neither guarantees renewal prices nor CoreWeave debt; enforceability in a particular insolvency has not been assessed. Nvidia order 8-K; claim 49.

Who holds the debt and who loses first

Equity is residual and faces valuation loss or dilution. Multiplying June's rounded 551m total common shares by $61.39 gives an illustrative $33.826bn market value, not a verified October capitalization. Nvidia's disclosed 47,213,353 January shares would equal 8.57% of that June share count if unchanged; its filed 11.5% was a January Class A percentage. Nvidia is supplier, investor and conditional capacity purchaser, but “main beneficiary” is a comparative judgment this note cannot establish. Q2 10-Q; Nvidia 13G/A; claims 17–18, 31.

Identified unsecured notes/converts total $20.817bn after September. Secured creditors have priority in their collateral, but there is no guaranteed sequential loss waterfall across separate SPVs and parent guarantees. Most June DDTLs retain parent recourse; DDTL 4.0's limited recourse has carve-outs and its rating is not a recovery guarantee. Vendor financing of $5.102bn includes equipment security; short maturity alone does not create legal seniority. Customers' $9.692bn deferred revenue represents service obligations whose recovery requires contract/entity analysis rather than an assumed universal unsecured ranking. The 78-cent tertiary quote applies to a particular bond snapshot, not all unsecured paper. Q2 10-Q, Notes 2/10; closing 8-K; claim 34.

What the securities discount

Using June's rounded share count and the 16 October price gives $33.826bn illustrative market cap, or 2.64× midpoint 2026 revenue guidance. Combining this with $42.151bn gross-additions debt and June $5.524bn cash/$0.015bn securities gives $70.438bn EV excluding leases, or 11.66× annualized Q2 EBITDA. These mixed-date illustrations omit subsequent cash flows and share changes; restricted cash is not deducted as freely available cash. They cannot by themselves establish whether equity is fairly valued. Q2 10-Q; August outlook; claims 22, 31 (B arithmetic; C valuation illustration).

CDS above 1,000bp and bond yields above 15% indicate severe repricing. With flat hazard and assumed 40% recovery, five-year risk-neutral default probability is 1 − exp[−spread ×5/0.60]: 56.5% at 1,000bp and 63.0% at 1,194.5bp. These are simplified pricing estimates, not real-world default forecasts; a bond yield alone cannot identify a probability without benchmark rates, recovery and liquidity assumptions. Positive equity value can coexist with substantial default risk because equity retains upside in survival states. Dilution, liquidity premia and divergent beliefs are possible explanations, not an exhaustive pair of reconciliations (claims 33–34; C model assumptions).

Conflicts and open questions

  • Financing pressure versus access (25 October). IFR’s 23 October sector freeze report qualifies the note’s earlier lack of verified post-selloff financing obstacles, but the CEO’s range-of-options memo and Huang’s working-capital argument support a less absolute interpretation than universal closure. IFR’s Bernstein $85bn/$104bn funding/backlog estimate is an analyst scenario with an older backlog perimeter, not a filed replacement for claim 12. No new closed CoreWeave financing or declared default is established by these sources. IFR; CNBC; Huang interview.

  • Silicon Data dated display versus FAQ (25 October). The dated 24 October H100 card/chart says $2.88; the same page’s undated FAQ says $2.53. The dated display supersedes the prior source-access limitation, while its Saturday chart point does not establish publication freshness or complete-month coverage. Neither benchmark is CoreWeave’s realized rent. Silicon Data; claim 57.

  • New rental evidence versus the prior source limitation (21 October). The note previously had only D-grade tertiary rental-index figures. OCPI now supplies primary 20 October settlements and dated history (claim 39). This improves the evidence for current rental demand while leaving CoreWeave utilization, reserved-contract renewals and resale recoveries unresolved. At the 21 October check, Silicon Data’s page said daily readings were temporarily unavailable; the prior 17 October $2.82 observation remains historical. The 25 October re-fetch recovers dated 21–24 October card/chart readings (claim 57), with a conflicting undated FAQ. This supersedes the prior access limitation without proving uninterrupted publication coverage. Ornn H100; Ornn B200; Silicon Data.

  • Debt perimeter (21 October). CNBC’s 20 October ~$51.6bn headline explicitly includes about $35bn in notes, bonds and loans. It is broader than filed June debt principal of $35.551bn (claim 20); the existing June debt-plus-operating-lease calculation is separately $51.870bn (claim 25). These are not comparable successive principal balances, and neither replaces the mixed-date gross-additions illustration. CNBC 20 Oct; Q2 10-Q.

  • Cash coverage: original note versus cross-check. The original judged contracts to cover debt service comfortably and said CoreWeave could service debt if customers paid and no more equipment was bought. The review agrees that demand is contracted but finds no maturity-matched cash proof: RPO recognition and assumed EBITDA margins omit prepayment amortization, delivery spending, restricted cash and borrower-level service. The revised Analysis retains the scenarios and 2.36× EBITDA/net-interest ratio without calling them cash coverage.

  • Profitability: original note versus cross-check. The original said CoreWeave “cannot be” GAAP-profitable while growing. The review finds that growth alone does not prohibit profit; utilization, pricing, depreciation and financing costs jointly matter. The evidence establishes current losses and a large financing burden, not an accounting impossibility.

  • Initial-term returns and renewals. The original inferred a 5.6-year payback, universal unrecovered one-to-three-year GPU tails and first large roll-offs in 2027–2029. The review corrects the mixed-cohort ratio to 5.8 years and rejects those payback/timing deductions. Management says initial contracts repay asset debt and produce attractive returns, while renewal exposure is limited; it reports A100/H200 renewal examples. The review cannot independently prove management's returns either. Cohort cash flows are needed to resolve this disagreement. September presentation, slide 10; corrected transcript, pp. 8/11.

  • Funding access. The original called the unsecured market closed at acceptable cost and inferred a next $30–40bn raise. The review supports substantial external-financing dependence but finds neither a complete funding-needs calculation nor evidence that all markets closed. The convert and 35m-share ATM are counterevidence to inevitable exclusion, but predate the selloff; authorization, the anticipated 30-day restriction and actual issuance must be distinguished. Closing 8-K; ATM release; September 8-K.

  • Recovery and Nvidia support. The original described a sequential equity/unsecured/SPV loss waterfall, treated short vendor maturities as seniority and presented Nvidia as backstop and main beneficiary. The review finds collateral priority directionally relevant but stresses parent recourse, separate borrowers and guarantees. Nvidia's conditional purchases and termination rights weaken unconditional rescue assumptions; the note lacks evidence to rank comparative beneficiaries. Insolvency enforceability remains unassessed. Q2 10-Q, Note 10; Nvidia order 8-K.

  • What triggered the 14 October fall. The original/coordinator framed it as CPI-driven; contemporary reporting also framed it as credit-market stress. Claim 32's CPI surprise coincided with the share decline but does not establish causality. The 14 October CNBC page was previously unavailable, so those historical quotes remain snippet-based; the 19–20 October AMP bodies were fetched directly on 21 October. The review supports repricing while rejecting certainty about the trigger.

  • CDS level. Reported snapshots range from above 1,000bp through 1,140bp to ICE's reported 1,194.5bp intraday peak. The review corroborates broad stress (B) but has no primary ICE series: exact quote/model estimate are C and June's ~452bp remains unverified. The review fetched Bloomberg's lead; the application fetch was unavailable, with TNW reporting the same peak. A simplified risk-neutral probability is not a real-world forecast. Bloomberg; TNW.

  • Bond price and dates. The original lead said 76 cents/~16%, and the note used TradingNews's ~78/>16% for 2032s; the review grades that tertiary claim D rather than the note's C. BondTerminal shows 81.504/14.45% YTW dated 15 October (also D); CNBC's 14 October yield snippets are another snapshot. MT Newswires already reports the 2031s' 15.78% on 15 October, so it is not uniquely a 16 October observation. Times/methodologies may differ; no TRACE tape was obtained. None of these marks establishes the price of all ~$21bn unsecured paper. MT Newswires; BondTerminal; claim 34.

  • Daily moves. One aggregator (roic.ai) reported an 8.3% fall on 15 October; Yahoo closes and CNBC show +5.9%. The Yahoo close series remains in use; the review checked the supplied-price arithmetic, not the exchange's original daily tape.

  • Capex and prepayments. Q2 cash PP&E purchases of $6.422bn differ from company-defined $9.4bn capex because financed/accrued additions are excluded from the cash line. The CSV uses cash purchases. Likewise, deferred revenue's $1.507bn balance growth is not its $1.365bn cash-flow contribution. Expected improved new-contract margins and prepayments in ~70% of Q2 deals qualify a static fleet-wide funding calculation without proving free cash flow. Q2 10-Q; corrected call, p. 9; September presentation, slide 7.

  • Meta $21bn. The original considered replacement versus addition unresolved. The review points to the April 8-K's new capacity plus prior-option exercise and Reuters's explicit report that ~$21bn is additional to September's $14.2bn. This supports an incremental announced commitment, while neither cumulative figure equals current remaining backlog. April 8-K; Reuters.

  • Microsoft trend. Customer A fell from 72% to 36%, but labels may identify different customers across periods. The original inference of falling Microsoft dependence remains unverified for 2026; the observed largest-customer concentration fell.

  • Run-rate versus actual. The company's April framing is 3.3× on fully drawn $53.5bn debt/$16.1bn run-rate EBITDA. The original's ~7× actual-EBITDA comparison uses subsequent gross-additions debt; June debt on annualized Q2 EBITDA is 5.89×, and fully drawn debt on that same denominator is 8.86×. The review validates arithmetic on supplied April inputs but could not independently read the image-only numeric slide. Delivery assumptions, dates and denominators must remain explicit. April supplement.

  • Equity and credit pricing. The original said the two could reconcile only through dilution or credit illiquidity. The review considers that exhaustive framing unsupported: survival-state upside can preserve positive equity value alongside substantial default risk. Mixed-date valuation multiples do not settle which market is right.

  • Insider selling. Form 144 volume (100 notices in three months) is primary; dollar totals circulate through aggregators. The cited 10b5-1 plans were adopted in November 2025 and March 2026, so sales were pre-planned but not therefore uninformative.

  • Verification limits and grades. The FT McBee interview was not fetched; June debt plus operating lease liabilities is independently reproducible at $51.870bn, but no “>$35bn raised this year” quote is adopted. Nvidia's January holdings/Class A percentage now have a primary 13G/A; an October stake does not. Corporate ratings and older tertiary rental indices remain D; the newly fetched OCPI readings in claim 39 are A for the publisher’s observations. Primary guidance is A that management issued it, not proof of achievement.

  • Core Scientific. CoreWeave remains Core Scientific's largest hosting tenant after the failed merger; megawatt energisation in 2026 was not verified.

Signals to watch

Signal Current value As of Source Why it matters
5-year CDS CNBC/FactSet 1,065.84bp on 21 Oct; prior ~1,082bp 19 Oct/nearly 1,081bp 20 Oct and 1,194.5bp intraday peak 15 Oct. Separate updated CNBC 1,145bp quote has no fixing date 2026-10-21 dated; undated quote in 21 Oct article updated 23 Oct CNBC/FactSet; CNBC update; claim 33 Next: dated quote/primary tape; do not label undated publication marks as closes or physical default forecasts
9.75% 2031 senior note yield Latest dated 15.97% on 20 Oct; prior 15.78% on 15 Oct. Updated CNBC unsecured ~15% lacks security/fixing date 2026-10-20 dated; undated quote in 21 Oct article updated 23 Oct CNBC 20 Oct; MT Newswires; CNBC update; claim 34 Next: dated security-specific trade/yield and actual new-issue terms; publication snapshots alone do not establish closure or default
Share price $61.39; −25.2% week; −66.6% peak; +53.5% IPO 2026-10-16 Yahoo Finance; claim 31 Equity issuance capacity and convert dilution
Revenue backlog / RPO $104.2bn / $103.7bn at June; >$25bn early-Q3 commitments separately announced 2026-06-30; announcement 2026-08-11 September presentation; Q2 10-Q Delivery and revenue conversion; distinguish revenue recognition from collections
Total debt principal $35.551bn June; $42.151bn gross-additions illustration before repayments/other movements 2026-09-22 Q2 10-Q; closing 8-K Draws, amortization and updated debt schedule
New secured-loan pricing / financing access DDTL 5.5 SOFR+5.5% versus 4.0 SOFR+2.25% remain August/March terms. IFR 23 Oct reports sector financing delays; CNBC reports CEO’s borrowing/equity/prepayment options; Huang says capital scarce despite strong demand. No new CoreWeave financing established by these reports 2026-08-10 (5.5); reporting 2026-10-21–23 releases 20, 26; IFR; CNBC; Huang; claims 55–56, 58 Next: actual announced financing, draw conditions and pricing after selloff; distinguish sector constraints, opinions, committed capacity and funds drawn
Interest expense / revenue 24.9% Q2; Q3 midpoint guide 25.5% 2026-08-11 Q2 release; August outlook Financing burden; not cash debt-service coverage
Largest-customer share 36%, 26%, 10% for A/B/C 2026-Q2 Q2 10-Q Concentration; customer identities cannot be assumed across periods
Rents and renewals OCPI 24 Oct H100 $3.02/H200 $6.20/B200 $9.57 per GPU-hour; separate Silicon Data H100 $2.88 dated card/chart versus undated $2.53 FAQ. Prior 20 Oct and daily history retained in claims 39/57; company renewal examples remain September disclosures 2026-10-24 benchmark date; fetched 2026-10-25; company 2026-09-17 claims 39, 43–45, 57; Ornn H100; Ornn B200; Ornn H200; Silicon Data Next: new dated daily settlements and archive; no 25 Oct OCPI settle displayed. Compare cohort renewals without substituting benchmarks for reserved-contract rents or assuming complete-month coverage
Covenant actions Unlimited cures before 28 Oct 2026; then no more than three consecutive calendar months in any four; first DSCR test 31 Oct 2027 Existing 2025-12-31 terms, rechecked 2026-10-25 Amendment 8-K; claims 27, 51 Next: 28 Oct 2026 cure-frequency transition; DSCR first test 31 Oct 2027. Transition alone is not default or maturity
Insider Form 144 filings 100 in Jul–Oct 2026 2026-10-13 EDGAR; claim 37 Insider conviction; notices are not aggregate realized proceeds
Capex versus revenue guidance $35–39bn versus $12.4–13.2bn 2026-08-11 August outlook Reconcile cash PP&E, cash generation, prepayments and committed financing
ATM / liquidity 35m-share authorization; anticipated initial ≥30-day sales restriction; June facility availability $10.014bn; actual ATM proceeds not established by 21 Oct inventory check 2026-09-17 (ATM); 2026-06-30 (facilities); checked 2026-10-21 claims 41, 48; September 8-K; Q2 10-Q; SEC inventory Next: disclosed issuance/net proceeds, eligible borrowing and Q3 liquidity reconciliation; Q3 release date not independently confirmed in this update
Lease / expansion commitments $35.5bn uncommenced undiscounted lease payments, specified exclusions; planned India 240MW 2026-06-30 (leases); 2026-10-07 (India) claims 46–47; Q2 10-Q; India announcement Fixed commitments, delivery timing and future capital needs
Remediation of material weaknesses Disclosure controls ineffective at June 30; IT general controls, segregation of duties and qualified staffing weaknesses persisted; remediation ongoing 2026-06-30 (assessment); 2026-08-12 (filing) Q2 10-Q, Item 4; claim 54 Next test: Q3 2026 10-Q, Item 4—whether management reports effective disclosure controls, completed remediation supported by testing, continuing weaknesses or additional measures
Hyperscaler demand / capex releases Microsoft and Alphabet results due 28 Oct; Amazon 29 Oct (5pm ET call); none released at this cutoff Schedule checked 2026-10-25 Microsoft; Alphabet issuer notice; Amazon Next: 28–29 Oct actual cloud demand, capex and funding disclosures; previews are not results
Rate decision / funding benchmark FOMC meeting scheduled 27–28 Oct; no October decision yet Schedule checked 2026-10-25 Federal Reserve calendar Next: 27–28 Oct policy meeting; funding costs affect expansion economics

Sources

Original sources accessed 2026-10-17 unless otherwise identified. Update sources CF22, CU23, IFR23, HU22, OH, OB, OHH, SDH, CA, MS28, GO28, AM29 and FED27 re-fetched 2026-10-25; CNBC/IFR full bodies and Silicon Data embedded chart were accessible by direct request. SEC requests used generic User-Agent research-bot [email protected]. Dated 21 October CDS is separate from undated 1,145bp/~15% publication snapshots; neither undated quote becomes a CSV observation. Update sources CN19, CN20, FT20, OH, OB, OCPI, GS20, SDH, SECINV and amendment CA fetched 2026-10-21; CNBC AMP bodies were accessible by direct fetch despite browser-fetch restrictions. New figures were fetched from the linked sources when applying the cross-check. Bloomberg’s direct page was unavailable on the application fetch; exact market marks retain the review’s verification limits.

  1. CoreWeave, Form 10-Q for the quarter ended 30 June 2026, filed 2026-08-12. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000366/crwv-20260630.htm

  2. CoreWeave, "CoreWeave Reports Strong Second Quarter 2026 Results", 8-K Exhibit 99.1, 2026-08-11. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000362/coreweave2q26earningspress.htm

  3. CoreWeave, Form 10-Q for the quarter ended 31 March 2026, filed 2026-05-08. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000222/crwv-20260331.htm

  4. CoreWeave, Q1 2026 results release, 8-K Exhibit 99.1, 2026-05-07. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000220/coreweave1q26earningspress.htm

  5. CoreWeave, Form 10-K for the year ended 31 December 2025, filed 2026-03-02. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000104/crwv-20251231.htm

  6. CoreWeave, Q4 2025 results release, 8-K Exhibit 99.1, 2026-02-26. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000094/coreweave4q25earningspress.htm

  7. CoreWeave, Form 10-Q for the quarter ended 30 September 2025, filed 2025-11-13. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000062/crwv-20250930.htm

  8. CoreWeave, Q3 2025 results release, 2025-11-10. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000059/coreweave3q25earningspress.htm

  9. CoreWeave, Form 10-Q for the quarter ended 30 June 2025, filed 2025-08-13. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000041/crwv-20250630.htm

  10. CoreWeave, Q2 2025 results release, 2025-08-12. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000039/coreweave2q25earningspress.htm

  11. CoreWeave, Form 10-Q for the quarter ended 31 March 2025, filed 2025-05-15. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000014/crwv-20250331.htm

  12. CoreWeave, Q1 2025 results release, 2025-05-14. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000010/coreweave1q25earningspress.htm

  13. CoreWeave, 8-K Item 1.01, NVIDIA order form ($6.3bn, residual capacity through 13 Apr 2032), 2025-09-15. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000047/crwv-20250909.htm

  14. CoreWeave, 8-K Item 1.01, OpenAI order form ($6.5bn through 31 May 2031), 2025-09-25. https://www.sec.gov/Archives/edgar/data/1769628/000119312525216497/d17274d8k.htm

  15. CoreWeave, 8-K Item 1.01, Meta order form ($14.2bn through 14 Dec 2031), 2025-09-30. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000050/crwv-20250925.htm

  16. CoreWeave, 8-K Item 1.02, termination of Core Scientific merger agreement, 2025-10-31. https://www.sec.gov/Archives/edgar/data/1769628/000095010325014006/dp236631_8k.htm

  17. CoreWeave, 8-K Item 8.01, termination of Series C put right, 2025-10-06. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000052/crwv-20250925.htm

  18. CoreWeave, 8-K Item 1.01, First Amendment to DDTL 3.0 credit agreement, 2026-01-02. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000003/crwv-20251231.htm

  19. CoreWeave, 8-K, NVIDIA $2bn private placement and collaboration framework, 2026-01-26. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000044/crwv-20260123.htm

  20. CoreWeave, "CoreWeave Closes Landmark $8.5 Billion Financing Facility" (DDTL 4.0), 8-K Exhibit 99.1, 2026-03-31. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000129/ex991.htm

  21. CoreWeave, "CoreWeave and Meta Announce $21 Billion Expanded AI Infrastructure Agreement", 8-K Exhibit 99.1, 2026-04-09. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000154/ex991.htm

  22. CoreWeave, supplemental investor information for senior notes offering (capitalization and leverage), 8-K Exhibit 99.3, 2026-04-09. https://www.sec.gov/Archives/edgar/data/1769628/000119312526148912/d136714dex993.htm

  23. CoreWeave, 8-K, closing of 9.75% senior notes due 2031 and 1.75% convertible notes due 2032, 2026-04-14. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000164/crwv-20260409.htm

  24. CoreWeave/Jane Street, "Jane Street Signs $6 Billion AI Cloud Agreement with CoreWeave", 8-K Exhibit 99.1, 2026-04-15. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000167/ex991.htm

  25. CoreWeave, "CoreWeave Closes $3.1 Billion Loan Facility" (DDTL 5.0), 8-K Exhibit 99.1, 2026-05-18. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000236/ex9912.htm

  26. CoreWeave, "CoreWeave Closes $2.6 Billion Loan Facility" (DDTL 5.5), 8-K Exhibit 99.1, 2026-08-10. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000357/ex991pr.htm

  27. CoreWeave, 8-K, closing of $4.2bn 2.875% convertible senior notes due 2033 and capped calls, 2026-09-22; pricing release 2026-09-18. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000432/crwv-20260917.htm ; https://www.sec.gov/Archives/edgar/data/1769628/000176962826000432/ex991pricing.htm

  28. CoreWeave, "CoreWeave Closes $2.6 Billion Secured Debt Financing Facility" (DDTL 3.0), 8-K Exhibit 99.1, 2025-07-31. https://www.sec.gov/Archives/edgar/data/1769628/000176962825000033/ddtl30pressrelease-ex991x6.htm

  29. SEC EDGAR, CoreWeave Form 144 filings list. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001769628&type=144&dateb=&owner=include&count=100

  30. SEC EDGAR, Form 4, Michael Intrator, transactions through 2026-08-25. https://www.sec.gov/Archives/edgar/data/0001769628/000176962826000412/form4.xml

  31. Yahoo Finance chart API, CRWV daily closes, 2025-03-28 to 2026-10-16. https://query1.finance.yahoo.com/v8/finance/chart/CRWV?range=2y&interval=1d

  32. CNBC, "CoreWeave shares tumble as bond yields near 15% on concern about AI borrowing binge", 2026-10-14 (search snippet; page blocked to fetch). https://www.cnbc.com/2026/10/14/coreweave-stock-bond-yields-ai-debt.html

  33. CNBC, "CoreWeave credit default swaps hit distress levels as investors sour on AI debt", 2026-10-15 (snippet). https://www.cnbc.com/2026/10/15/coreweave-credit-default-swaps-hit-distress-levels-as-investors-sour-on-ai-debt.html

  34. CNBC Investing Club, "Why did CoreWeave stock get crushed this week?", 2026-10-16 (snippet). https://www.cnbc.com/investingclub/2026/10/16/coreweave-credit-default-swaps.html

  35. CNBC Daily Open, 2026-10-16 (snippet). https://www.cnbc.com/2026/10/16/cnbc-daily-open-ai-inflation-coreweave-.html

  36. The Next Web, "Nvidia's Huang says CoreWeave needs no backstop, as its credit swaps hit a record" (citing Bloomberg and ICE Data Services), 2026-10-15. https://thenextweb.com/news/huang-coreweave-backstop-stockholm

  37. TheStreet via Yahoo Finance, "CoreWeave stock plunges 12%, but Wall Street analyst says buy the dip" (citing Bloomberg CDS data), 2026-10-16. https://finance.yahoo.com/markets/stocks/articles/coreweave-stock-plunges-12-wall-223927844.html

  38. MT Newswires via Yahoo Finance, "CoreWeave Sharp Sell-Off About Cost of Funding, Not Demand, Analysts Say", 2026-10-16. https://finance.yahoo.com/markets/stocks/articles/coreweave-sharp-sell-off-cost-204945626.html

  39. CNN Business via Yahoo Finance, "Nasdaq sinks more than 2% as investors raise questions about AI debt", 2026-10-16. https://finance.yahoo.com/markets/stocks/articles/nasdaq-sinks-more-2-investors-191031142.html

  40. TradingNews, "CoreWeave Sinks to $60.96 as CDS Spreads Top 1,000bp", 2026-10-15 (tertiary). https://www.tradingnews.com/news/coreweave-sinks-to-60-usd-as-cds-spread-top-1000bp-and-35b-usd-debt

  41. investinglive, "US September CPI 3.7% vs 3.6% expected", 2026-10-14. https://investinglive.com/news/us-september-cpi-vs-3-6-expected-0/

  42. MarketBeat, "CoreWeave Q2 earnings call highlights", 2026-08-11 (auto-generated call summary). https://www.marketbeat.com/instant-alerts/coreweave-q2-earnings-call-highlights-2026-08-11/

  43. Uvik Software, "GPU Price Index", as of 2026-10-07 (cites SemiAnalysis contract index). https://uvik.net/blog/gpu-price-index/

  44. CoreWeave IR, "CoreWeave Expands Agreement with OpenAI by up to $6.5B", 2025-09-25 (via search snippet). https://investors.coreweave.com/news/news-details/2025/CoreWeave-Expands-Agreement-with-OpenAI-by-up-to-6-5B/default.aspx

  45. Blackstone, "CoreWeave Secures $7.5 Billion Debt Financing Facility led by Blackstone and Magnetar", May 2024 (via search snippet). https://www.blackstone.com/news/page/3/

  46. Motley Fool, "Nvidia just increased its stake by 95% in this AI company" (13F), 2026-05-26. https://fool.com/investing/2026/05/26/nvidia-just-increased-its-stake-by-95-in-this-ai-c

  47. PitchBook via Yahoo Finance, "CoreWeave's not-so-secret weapons: price hikes and an Nvidia trump card", 2026-10-16. https://finance.yahoo.com/markets/stocks/articles/coreweaves-not-secret-weapons-price-233000657.html

  48. Data file: data/coreweave-quarterly.csv (this project), compiled from sources 1–12.

  49. CoreWeave, Q2 2026 outlook presentation, 2026-08-11, p. 3 (primary guidance). https://s205.q4cdn.com/133937190/files/doc_financials/2026/q2/CoreWeave-Q2-26-Earnings-Outlook-Presentation.pdf

  50. CoreWeave, Q1 2026 outlook presentation, 2026-05-07, p. 3 (prior guidance). https://s205.q4cdn.com/133937190/files/doc_financials/2026/q1/CoreWeave-1Q26-Outlook-Presentation.pdf

  51. CoreWeave, corrected Q2 2026 earnings-call transcript, 2026-08-11, pp. 8–11. https://s205.q4cdn.com/133937190/files/doc_financials/2026/q2/CRWV-US-CORRECTED-TRANSCRIPT-CoreWeave-Q2-2026-Earnings-Call-11August2026.pdf

  52. CoreWeave, September convertible-offering presentation, 2026-09-17, especially slides 7, 10–11, 28, 30 and 37. https://www.sec.gov/Archives/edgar/data/1769628/000176962826000429/crwv2026convertpresentat.htm

  53. Nvidia, Schedule 13G/A, event date 2026-01-23 (47,213,353 shares; 11.5% of Class A). https://www.sec.gov/Archives/edgar/data/1045810/000104581026000008/xslSCHEDULE_13G_X01/primary_doc.xml

  54. CoreWeave, “CoreWeave Announces At-the-Market Offering Program,” 2026-09-17. https://investors.coreweave.com/news/news-details/2026/CoreWeave-Announces-At-the-Market-Offering-Program/default.aspx

  55. CoreWeave, 8-K, 2026-09-17 (ATM and anticipated initial sales restriction). https://www.sec.gov/Archives/edgar/data/1769628/000176962826000429/crwv-20260917.htm

  56. CoreWeave, “CoreWeave Continues to Contract New Compute Capacity at Higher Prices,” 2026-09-17. https://investors.coreweave.com/news/news-details/2026/CoreWeave-Continues-to-Contract-New-Compute-Capacity-at-Higher-Prices/default.aspx

  57. CoreWeave, “CoreWeave Enters India, Expanding AI Cloud Platform With AdaniConneX,” 2026-10-07. https://investors.coreweave.com/news/news-details/2026/CoreWeave-Enters-India-Expanding-AI-Cloud-Platform-With-AdaniConneX/default.aspx

  58. CoreWeave, April 8-K, filed 2026-04-09, Item 8.01 (Meta order dated 31 March). https://www.sec.gov/Archives/edgar/data/1769628/000176962826000154/crwv-20260331.htm

  59. Reuters via Investing.com, “Meta, CoreWeave deepen AI cloud partnership with fresh $21 billion deal,” 2026-04-09. https://www.investing.com/news/stock-market-news/coreweave-signs-21-billion-ai-cloud-deal-with-meta-4605144

  60. Bloomberg News, “CoreWeave Risk Gauge Hits Record, Pricing 60% Odds of Default,” 2026-10-15 (lead fetched by cross-check; direct application fetch unavailable). https://news.bloomberglaw.com/daily-tax-report-international/coreweave-risk-gauge-hits-record-pricing-60-odds-of-default

  61. Axios, “Warning signs are flashing on the AI trade. Here's where to spot them,” 2026-10-16. https://www.axios.com/2026/10/16/ai-coreweave-bonds-debt

  62. Axios, “CoreWeave roils the markets, raises warning flag for the AI trade,” 2026-10-15. https://www.axios.com/2026/10/15/ai-coreweave-bonds-stocks

  63. MT Newswires via Yahoo Finance, “Update: CoreWeave Execution Outweighs Financing Worries, BofA Says,” 2026-10-15, 5:14 p.m. EDT (retrieved search result; 15.78% quote). https://ca.finance.yahoo.com/news/coreweave-execution-outweighs-financing-worries-211401274.html

  64. BondTerminal, CoreWeave issuer page (15 October-dated aggregator snapshots; D-grade). https://bondterminal.com/issuers/coreweave-inc

Updated 2026-10-25 09:40 UTC · raw markdown · source